{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-019986","form_type":"8-K","ticker":"ARDX","cik":"0001437402","company_name":"ARDELYX, INC.","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.418994+00:00","generated_at":"2026-06-03T00:15:56.131126+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ardelyx Q1 product revenue $45.6M (IBSRELA $28.4M, XPHOZAH $15.2M); net loss $26.5M","bullets":["Q1 product-related revenue $45.6M: IBSRELA $28.4M (+149% YoY), XPHOZAH $15.2M (first full quarter after Oct 2023 approval).","Net loss $26.5M ($0.11/sh) vs $26.8M ($0.13/sh) in Q1 2023; cash & investments $202.6M.","Full-year 2024 IBSRELA net sales guidance raised to $140M-$150M.","SG&A expenses $53.0M (+$26.2M YoY) due to commercialization of both products.","Appointed Mike Kelliher as EVP Corporate Development and Strategy in March 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-019986","json":"https://secwatch.observer/filing/0001628280-24-019986.json","markdown":"https://secwatch.observer/filing/0001628280-24-019986.md","text":"https://secwatch.observer/filing/0001628280-24-019986.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1437402/000162828024019986/0001628280-24-019986-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1437402/000162828024019986/ardx-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:15:56.131126+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e30de2b3cc5382df1b989b3567ac600881010540","claim":"ARDELYX, INC. reported financial results for first quarter ended March 31, 2024.","evidence_excerpt":"On May 2, 2024, Ardelyx, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828024019986/0001628280-24-019986-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}